Clinical Trial Update: Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating triple combination therapy in type 2 diabetes patients with inadequate glycemic control on prior combination therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED